A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
- 29 November 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (51), 8085-8094
- https://doi.org/10.1016/j.vaccine.2010.10.004
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3Journal of Virology, 2010
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in HumansScience, 2010
- Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtypeVirology, 2009
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyVirology, 2009
- Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine developmentCell Host & Microbe, 2008
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 VirusJournal of Virology, 2008
- Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific MannerCell Host & Microbe, 2007
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007
- Monoclonal antibody-mediated enhancement of dengue virus infectionin vitroandin vivoand strategies for preventionProceedings of the National Academy of Sciences of the United States of America, 2007
- Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human FcγRIA (CD64) or FcγRIIA (CD32)Journal of Virology, 2006